Concepedia

Re-Evaluation of 400 Crimean-Congo Hemorrhagic Fever Cases in an Endemic Area: Is Ribavirin Treatment Suitable?

Fazılet Duygu, Kaya Turan, Pinar Baysan

Vector-Borne and Zoonotic Diseases · 2011 · 30 citations · 22 references

DOI

Abstract

Age, male gender, high levels of ALT, AST, WBC aPTT values, platelet levels, and decrease in these values during follow-up are indicative of a poor prognosis. Use of ribavirin is not required in treatment of CCHF.

References

22

Lassa Fever

Joseph B. McCormick, I. J. King, P. A. Webb et al. · New England Journal of Medicine · 1986 · 991 citations

, , +13

The Clinical Pathology of Crimean-Congo Hemorrhagic Fever

Robert Swanepoel, DK Gill, Ashley Shepherd et al. · Clinical Infectious Diseases · 1989 · 420 citations

Crimean-Congo Hemorrhagic Fever in Turkey

S. Sami Kartı, Zekaver Odabaşı, Volkan Korten et al. · Emerging infectious diseases · 2004 · 304 citations · Full text

Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin Therapy

Önder Ergönül, Aysel Kocagül Çelikbaş, Başak Dokuzoğuz et al. · Clinical Infectious Diseases · 2004 · 300 citations

, , +15

Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited

Önder Ergönül, Aysel Kocagül Çelikbaş, Nurcan Baykam et al. · Clinical Microbiology and Infection · 2006 · 259 citations · Full text

, , +5